Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Matthew Greenig"'
Publikováno v:
Open Biology, Vol 14, Iss 5 (2024)
Most successes in computational protein engineering to date have focused on enhancing one biophysical trait, while multi-trait optimization remains a challenge. Different biophysical properties are often conflicting, as mutations that improve one ten
Externí odkaz:
https://doaj.org/article/8ffedd5c6a95449f880744967c3da0b7
Autor:
Hayley Holt, David A. Jolliffe, Mohammad Talaei, Sian Faustini, Giulia Vivaldi, Matthew Greenig, Alex G. Richter, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Gwyneth A. Davies, Seif O. Shaheen, Adrian R. Martineau
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Prospective population-based studies investigating associations between reactive symptoms following SARS-CoV-2 vaccination and serologic responses to vaccination are lacking. We therefore conducted a study in 9003 adults from the UK general
Externí odkaz:
https://doaj.org/article/1f48cbac4e4f43ae89f1afb89b1bf498
Autor:
Mohammad Talaei, Sian Faustini, Hayley Holt, David A. Jolliffe, Giulia Vivaldi, Matthew Greenig, Natalia Perdek, Sheena Maltby, Carola M. Bigogno, Jane Symons, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Alex G. Richter, Seif O. Shaheen, Adrian R. Martineau
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults re
Externí odkaz:
https://doaj.org/article/b7da12e1b2c54b6dafee73e239876df6
Autor:
Jez L. Marston, Matthew Greenig, Manvendra Singh, Matthew L. Bendall, Rodrigo R.R. Duarte, Cédric Feschotte, Luis P. Iñiguez, Douglas F. Nixon
Publikováno v:
JCI Insight, Vol 6, Iss 24 (2021)
SARS-CoV-2 promotes an imbalanced host response that underlies the development and severity of COVID-19. Infections with viruses are known to modulate transposable elements (TEs), which can exert downstream effects by modulating host gene expression,
Externí odkaz:
https://doaj.org/article/5f450c2df1094712aae65226d29bf52d
Autor:
David A. Jolliffe, Sian E. Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Alex G. Richter, Adrian R. Martineau
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1601 (2022)
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of sociodemographic, behavioural, clinical, pharmacologic and nutritional factors could explain these differences. To investigate this hypothesis, we te
Externí odkaz:
https://doaj.org/article/6ecab6ed88594c469e61463d03cf769b
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
Cardiovascular disease accounts for millions of deaths each year and is currently the leading cause of mortality worldwide. The aging process is clearly linked to cardiovascular disease, however, the exact relationship between aging and heart functio
Externí odkaz:
https://doaj.org/article/dc2ee6487edd43af951ea85a6e437964
Autor:
Matthew Greenig
Publikováno v:
PeerJ, Vol 7, p e6711 (2019)
Since their discovery in the 1960s, further investigation into endogenous retroviruses (ERVs) has challenged the conventional view of viral sequences as exclusively parasitic elements. Once presumed to be a group of passive genetic relics, it is beco
Externí odkaz:
https://doaj.org/article/0b0b5a99b7954250b919d472fabe5c82
Monoclonal antibodies have emerged as a key class of therapeutics, and nanobodies are rapidly increasing in popularity following the approval of the first nanobody drug in 2019, yet the therapeutic development of these biologics remains a challenge.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e16e9deb764154648e69b40c62ef438
https://doi.org/10.1101/2023.04.28.538712
https://doi.org/10.1101/2023.04.28.538712
Autor:
David A Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Giulia Vivaldi, Sheena Maltby, Jane Symons, Nicola L Barlow, Alexa Normandale, Rajvinder Garcha, Alex G Richter, Sian E Faustini, Christopher Orton, David Ford, Ronan A Lyons, Gwyneth A Davies, Frank Kee, Christopher J Griffiths, John Norrie, Aziz Sheikh, Seif O Shaheen, Clare Relton, Adrian R Martineau
Publikováno v:
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19 : phase 3 randomised controlled trial (CORONAVIT) ', BMJ (Clinical research ed.), vol. 378, 071230, pp. e071230 . https://doi.org/10.1136/bmj-2022-071230
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) ', BMJ, vol. 378, e071230 . https://doi.org/10.1136/bmj-2022-071230
Jolliffe, D A, Holt, H, Greenig, M, Talaei, M, Perdek, N, Pfeffer, P, Vivaldi, G, Maltby, S, Symons, J, Barlow, N L, Normandale, A, Garcha, R, Richter, A G, Faustini, S E, Orton, C, Ford, D, Lyons, R A, Davies, G A, Kee, F, Griffiths, C J, Norrie, J, Sheikh, A, Shaheen, S O, Relton, C & Martineau, A R 2022, ' Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) ', BMJ, vol. 378, e071230 . https://doi.org/10.1136/bmj-2022-071230
ObjectiveTo determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) DesignPhase 3 open label randomised controlled trial.SettingUnited Kingdom.Pa
Autor:
David A. Jolliffe, Sian E. Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A. Davies, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Alex G. Richter, Adrian R. Martineau
Publikováno v:
Jolliffe, D A, Faustini, S E, Holt, H, Perdek, N, Maltby, S, Talaei, M, Greenig, M, Vivaldi, G, Tydeman, F, Symons, J, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Shaheen, S O, Richter, A G & Martineau, A R 2022, ' Determinants of Antibody Responses to SARS-CoV-2 Vaccines : Population-Based Longitudinal Study (COVIDENCE UK) ', Vaccines, vol. 10, no. 10, 1601 . https://doi.org/10.3390/vaccines10101601
Vaccines; Volume 10; Issue 10; Pages: 1601
Vaccines; Volume 10; Issue 10; Pages: 1601
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of sociodemographic, behavioural, clinical, pharmacologic and nutritional factors could explain these differences. To investigate this hypothesis, we te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fe18c222ac326d76cb2bd1a85a68b0
https://www.pure.ed.ac.uk/ws/files/306059976/Determinants_of_Antibody_Responses_to_SARS_CoV_2_Vaccines.pdf
https://www.pure.ed.ac.uk/ws/files/306059976/Determinants_of_Antibody_Responses_to_SARS_CoV_2_Vaccines.pdf